skip to main content

    Updated Visitor Guidelines

 

MENU

 

Bladder Cancer

Immunotherapy cancer drugs may impact vision

Although it is rare, knowledge of this risk is important both for the ophthalmologists who treat it and for the oncologists prescribing the anti-cancer treatment, say Michigan Medicine researchers. The cases of three recent patients, published in JAMA Ophthalmology, highlight the issue. Patients receiving immune checkpoint inhibitors developed uveal effusions and eye inflammation that affected their vision.

Women and sexuality after bladder cancer

Recovering sexuality after bladder cancer can be difficult for women. Daniela Wittmann, Ph.D., LMSW, CST, and LaShon Day, PA-C, from the University of Michigan Department of Urology, were featured in a series of four webinars on this topic, sponsored by the Bladder Cancer Awareness Network.

Beautiful Music

Immunotherapy is a newer form of treatment that attacks cancer by boosting the body’s own immune system and ability to fight it. Clint Lavens comes to the Rogel Cancer Center every three weeks for infusion treatments at a special clinical area devoted to evaluating new cancer therapies, the Ravitz Foundation Center for Translational Research.

Something to Cheer About

Charles Albrecht was making the most of his active retirement, but a diagnosis of bladder cancer came between him and these good times. After receiving traditional treatment without much success, Charles decided to enter an immunotherapy clinical trial.

Naproxen plus acid blocking drug shows promise in preventing bladder cancer

Researchers used the proton pump inhibitor omeprazole, a commonly used acid inhibitor, in combination with naproxen and found it was effective at preventing bladder cancer in an animal model.

Pages